Pages that link to "Q45861074"

The following pages link to Level of virulent virus excreted by infected pigs previously vaccinated with different glycoprotein deleted Aujeszky's disease vaccines (Q45861074):

Displaying 26 items.

• Virological Protection of Sows upon Challenge with Aujeszky's Disease Virus After Multiple Vaccinations with Attenuated or Inactivated Vaccines (Q40642072) (← links)
• Vaccination of pigs against pseudorabies virus with plasmid DNA encoding glycoprotein D. (Q40962235) (← links)
• Efficacy of a Mixed Glycoprotein Vaccine against Pseudorabies in Pregnant Sows (Q41061260) (← links)
• Pseudorabies virus eradication by area-wide vaccination is feasible (Q41073296) (← links)
• Protective Effect of Glycoprotein gC-Rich Antigen against Pseudorabies Virus (Q41095907) (← links)
• Interaction of pseudorabies virus with immortalized porcine B cells: Influence on surface class I and II major histocompatibility complex and immunoglobulin M expression (Q41354842) (← links)
• Vaccination strategies for improving the efficacy of programs to eradicate Aujeszky's disease virus (Q41529951) (← links)
• Dynamics of pseudorabies virus infections in vaccinated pig populations: A review (Q41607657) (← links)
• Limited protection conferred by a DNA vaccine against a lethal pseudorabies virus infection at day 5 postvaccination (Q41876920) (← links)
• Single inoculation of replication-defective adenovirus-vectored vaccines at birth in piglets with maternal antibodies induces high level of antibodies and protection against pseudorabies (Q45020367) (← links)
• Prime-boost immunization using DNA vaccine and recombinant Orf virus protects pigs against Pseudorabies virus (Herpes suid 1). (Q45414988) (← links)
• CpG motif in ATCGAT hexamer improves DNA-vaccine efficiency against lethal Pseudorabies virus infection in pigs (Q45457519) (← links)
• Effective protection of pigs against lethal Pseudorabies virus infection after a single injection of low-dose Sindbis-derived plasmids encoding PrV gB, gC and gD glycoproteins (Q45479405) (← links)
• A study of the ability of a TK-negative and gI/gE-negative pseudorabies virus (PRV) mutant inoculated by different routes to protect pigs against PRV infection. (Q45738563) (← links)
• The response of pigs inoculated with a thymidine kinase-negative (TK-) pseudorabies virus to challenge infection with virulent virus (Q45744742) (← links)
• Immune responses in pigs infected with porcine reproductive and respiratory syndrome virus (PRRSV) (Q45755760) (← links)
• No massive spread of pseudorabies virus in vaccinated sow herds. (Q45761843) (← links)
• Study of the delivery of the gD gene of pseudorabies virus to one-day-old piglets by adenovirus or plasmid DNA as ways to by-pass the inhibition of immune response by colostral antibodies (Q45761853) (← links)
• The influence of maternal immunity on the transmission of pseudorabies virus and on the effectiveness of vaccination (Q45763276) (← links)
• Comparison of two pseudorabies virus vaccines, that differ in capacity to reduce virus excretion after a challenge infection, in their capacity of reducing transmission of pseudorabies virus (Q45764412) (← links)
• Glycoprotein E of pseudorabies virus and homologous proteins in other alphaherpesvirinae (Q45782611) (← links)
• Correlation between gI, gII, gIII, and gp 50 antibodies and virus excretion in vaccinated pigs infected with pseudorabies virus (Q45880164) (← links)
• Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): Aujeszky's disease (Q47159904) (← links)
• Herd immunity after vaccination: how to quantify it and how to use it to halt disease (Q73636871) (← links)
• Technical requirements for the licensing of pseudorabies (Aujeszky's disease) vaccines in the European Union (Q77798342) (← links)
• Sulfolipo-cyclodextrin in squalane-in-water as a novel and safe vaccine adjuvant (Q78164032) (← links)